Please assess the completion status of the following clinical trial:

Trial Title: Sayana® Press Self-injection Study in Malawi

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Age 18-40, inclusive~* In general good health (participant verbally reports she feels well)~* Able to understand and willing to sign an informed consent document~* Willing to give contact information for follow-up~* Agree to have follow-up visits/interviews~* Willing to be randomized to the self-injection arm or provider-administered injection arm~* Menstrual period started within the past 7 days (for new DMPA users)~* Meet eligibility criteria for receiving DMPA per WHO Medical Eligibility Criteria (MEC)~Exclusion Criteria:~Pregnancy~* Plans to become pregnant in the next 12 months~* Plans to relocate outside the study area in the next 12 months~* Any condition (social or medical) which in the opinion of the investigator would make study participation unsafe or would interfere with adherence to study requirements or complicate data interpretation

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- self-injection (Type: ACTIVE_COMPARATOR): Women randomized to this arm will be trained to self-inject Sayana Press at home every three months
- provider injection (Type: ACTIVE_COMPARATOR): Women randomized to this arm will received Sayana press from a family planning provider every three months.

Based on this trial design, predict the completion outcome and termination type (if applicable).